Nelson, Loomis, and Fischetti were the ones who first characterized enzybiotics as a kind of experimental antibacterial treatment. The name is a portmanteau of the terms "enzyme" and "antibiotics," which were combined to form the term. Because of the antibacterial and antimicrobial qualities that they possess, enzymes have seen widespread use. Study on enzybiotics is based on proteolytic enzymes known as endolysins, which have shown to be particularly efficient in battling a variety of bacteria and serve as the foundation for this research. Endolysins are a very effective method of lysing bacterial cells. They are derived from bacteriophages and have a long history of use. The problem of antibiotic resistance, which has allowed for the spread of drug-resistant microorganisms that pose a huge danger to animal and human health around the world, is the primary motivation for the majority of the research being conducted on enzybiotics.
How You Will Benefit
(I) Insights, and validations about the following topics:
Chapter 18: Discovery and development of cephalosporins
Chapter 19: OBPgp279
Chapter 20: ESKAPE
Chapter 21: Multidrug-resistant bacteria
(II) Answering the public top questions about enzybiotics.
(III) Real world examples for the usage of enzybiotics in many fields.
(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of enzybiotics' technologies.
Who This Book Is For
Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of enzybiotics.